发明授权
- 专利标题： Compounds having CRTH2 antagonist activity
- 专利标题（中）： 具有CRTH2拮抗活性的化合物
-
申请号： US13180157申请日： 2011-07-11
-
公开(公告)号： US08268878B2公开(公告)日： 2012-09-18
- 发明人: Richard Edward Armer , Graham Michael Wynne , Colin Richard Dorgan , Peter David Johnson
- 申请人： Richard Edward Armer , Graham Michael Wynne , Colin Richard Dorgan , Peter David Johnson
- 申请人地址： GB Abingdon
- 专利权人： Oxagen Limited
- 当前专利权人： Oxagen Limited
- 当前专利权人地址： GB Abingdon
- 代理机构： Sterne, Kessler, Goldstein & Fox PLLC
- 优先权： GB0614608.8 20060722; GB0624176.4 20061204
- 主分类号： A61K31/40
- IPC分类号： A61K31/40 ; C07D209/04
摘要：
Compounds of general formula (I) wherein R is phenyl optionally substituted with one or more halo substituents; and their pharmaceutically acceptable salts, hydrates, solvates, complexes or prodrugs are useful in orally administrable compositions for the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis.
公开/授权文献
- US20110268693A1 Compounds Having CRTH2 Antagonist Activity 公开/授权日：2011-11-03
信息查询
